Retraction notice to “Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer” [International Journal of Biological Macromolecules 245 (2023) 125510] (International Journal of Biological Macromolecules (2023) 245, (S0141813023024042), (10.1016/j.ijbiomac.2023.125510))
2
